Treatment of Acute Massive Pulmonary Embolism

Oct 25, 2017 by in ONCOLOGY Comments Off on Treatment of Acute Massive Pulmonary Embolism

Fig. 1a Dilated right ventricle in the setting of acute massive PE Fig. 1b Dilated right ventricle with large right atrial thrombi Fig. 1c Dilated right ventricle with large right…

read more

and von Willebrand Factor

Oct 25, 2017 by in ONCOLOGY Comments Off on and von Willebrand Factor

Fig. 1 VWF functions: After the platelets detect any defect in vascular wall, shear rate leads to the initial arrest and attachment of platelet at the site of injury. Shear-induced…

read more

Treatment of Thrombosis and Embolism

Oct 25, 2017 by in ONCOLOGY Comments Off on Treatment of Thrombosis and Embolism

Absolute contraindications: *Active internal bleeding or DIC *Recent cerebrovascular event (including TIA) *Recent neurosurgery or intracranial trauma (<3 months) *Absolute contraindication to anticoagulation Relative contraindications: *Recent CPR, major surgery, obstetrical…

read more

and Arterial Thrombosis: Is There a Link?

Oct 25, 2017 by in ONCOLOGY Comments Off on and Arterial Thrombosis: Is There a Link?

Fig. 1 Prevalence of carotid plaques in patients with unprovoked and secondary DVT and in the control subjects [8] Subsequently, three studies have provided further evidence in support of the…

read more

Diagnosis of Pulmonary Embolism

Oct 25, 2017 by in ONCOLOGY Comments Off on Diagnosis of Pulmonary Embolism

Fig. 1 Planar perfusion scintigraphy in anterior-posterior projection showing a classic segmental wedge-shaped perfusion defect Only a few years after the introduction of perfusion scintigraphy supplemental ventilation scintigraphy was introduced…

read more

Review of the Evidence to Support Neuromuscular Electrical Stimulation in the Prevention and Management of Venous Disease

Oct 25, 2017 by in ONCOLOGY Comments Off on Review of the Evidence to Support Neuromuscular Electrical Stimulation in the Prevention and Management of Venous Disease

Fig. 1 PRISMA flow diagram of systematic review evaluating the role of neuromuscular stimulation in venous disease 4 Physical Parameters Comparison between trials is hindered by variations in protocols and…

read more

Vein Thrombosis in Intensive Care

Oct 25, 2017 by in ONCOLOGY Comments Off on Vein Thrombosis in Intensive Care

Fig. 1 Panel A:schematic report of changes in DVT incidence in ICU after introduction of heparin prophylaxis. Panel B ICU patients with DVT have a longer duration of mechanical ventilation,…

read more

Treatment of Venous Thromboembolism in Patients with Cancer

Oct 25, 2017 by in ONCOLOGY Comments Off on Treatment of Venous Thromboembolism in Patients with Cancer

Compound Dosage Bemiparin 115 IU/Kg/od Dalteparin 200 IU/Kg/od Enoxaparin 100 IU/kg/bid or 150 IU/kg/od Nadroparina 90 IU/Kg/bid or 180 IU/kg/od Reviparin 100 IU/Kg/bid Tinzaparin 175 IU/Kg/od Although in clinical practice UFH has virtually been replaced by LMWHs, we…

read more
Get Clinical Tree app for offline access